WallStreetZenWallStreetZen

NYSEMKT: LCTX
Lineage Cell Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lineage Cell Therapeutics earnings were -$40.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest LCTX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$30.5M, up 636% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LCTX reported annual earnings of -$18.6M, with -13.4% growth. The next LCTX earnings date is Nov 5, 2025.

LCTX earnings history

Current Revenue
$10.9M
Current Earnings
-$40.9M
Current Profit Margin
-374.8%

LCTX Return on Equity

Current Company
-60.2%
Current Industry
-10.1%
Current Market
30.7%
LCTX's Return on Equity (-60.2%)... subscribe to Premium to read more.
High Return on Equity Performance

LCTX undefined

Current Company
-39.7%
Current Industry
-0.2%
LCTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LCTX announces earnings.

LCTX undefined

Current Company
-51.11%
Current Industry
6.4%
LCTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LCTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LCTX-$40.28M-$40.91MN/A-$0.18
QSI-$99.60M-$106.46MN/A-$0.68
BNTC-$34.24M-$37.92MN/A-$0.01
PRTC$57.19M$50.68MN/A$1.70
OCGN-$50.68M-$56.94MN/A-$0.20
View Top Biotech Stocks

LCTX earnings dates

Next earnings date
Nov 5, 2025

Lineage Cell Therapeutics Earnings Reports & History FAQ

What were Lineage Cell Therapeutics's earnings last quarter?

On LCTX's earnings call on Invalid Date, Lineage Cell Therapeutics (NYSEMKT: LCTX) reported Q2 2025 earnings per share (EPS) of -$0.13, up 333.33% year over year. Total LCTX earnings for the quarter were -$30.46 million. In the same quarter last year, Lineage Cell Therapeutics's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Lineage Cell Therapeutics stock.

When does Lineage Cell Therapeutics report earnings?

The next LCTX earnings call is Invalid Date. Add LCTX to your watchlist to be reminded of Lineage Cell Therapeutics's next earnings date.

Is Lineage Cell Therapeutics profitable or losing money?

As of the last Lineage Cell Therapeutics earnings report, Lineage Cell Therapeutics is currently losing money. Lineage Cell Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$40.91 million, a 69.14% increase year over year.

What was LCTX's earnings growth in the past year?

As of Lineage Cell Therapeutics's earnings date in Invalid Date, Lineage Cell Therapeutics's earnings has grown year over year. LCTX earnings in the past year totalled -$40.91 million.

What are Lineage Cell Therapeutics's earnings expectations?

The current EPS estimate for Lineage Cell Therapeutics's earnings report in Invalid Date is -$0.02.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.